BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16884152)

  • 1. Chronic obstructive pulmonary disease, inflammation and PDE4 inhibitors.
    Halpin DM
    Br J Hosp Med (Lond); 2006 Jul; 67(7):370-4. PubMed ID: 16884152
    [No Abstract]   [Full Text] [Related]  

  • 2. Phosphodiesterase 4 inhibitors: antiinflammatory therapy for chronic obstructive pulmonary disease at last?
    Kerstjens HA; Timens W
    Am J Respir Crit Care Med; 2003 Oct; 168(8):914-5. PubMed ID: 14555456
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inflammatory lung and systemic disease].
    Med Monatsschr Pharm; 2005 Jul; 28(7):254-5. PubMed ID: 16038131
    [No Abstract]   [Full Text] [Related]  

  • 4. COPD, inflammation and its modulation by phosphodiesterase 4 inhibitors: time to look beyond the FEV1.
    Celli B
    Chest; 2006 Jan; 129(1):5-6. PubMed ID: 16424403
    [No Abstract]   [Full Text] [Related]  

  • 5. 4D or not 4D - the emetogenic basis of PDE4 inhibitors uncovered?
    Giembycz MA
    Trends Pharmacol Sci; 2002 Dec; 23(12):548. PubMed ID: 12457768
    [No Abstract]   [Full Text] [Related]  

  • 6. [Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases].
    Xia XD; Dai YR; Xu ZJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan; 27(1):57-9. PubMed ID: 14989829
    [No Abstract]   [Full Text] [Related]  

  • 7. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CC-10004 .
    Khobzaoui M; Gutke HJ; Burnet M
    Curr Opin Investig Drugs; 2005 May; 6(5):518-25. PubMed ID: 15912967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective phosphodiesterase 4 inhibitors in the treatment of allergy and inflammation.
    Smith VB; Spina D
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1136-41. PubMed ID: 16312135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase-4: selective and dual-specificity inhibitors for the therapy of chronic obstructive pulmonary disease.
    Giembycz MA
    Proc Am Thorac Soc; 2005; 2(4):326-33; discussion 340-1. PubMed ID: 16267357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AWD-12-281 (inhaled) (elbion/GlaxoSmithKline).
    Gutke HJ; Guse JH; Khobzaoui M; Renukappa-Gutke T; Burnet M
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1149-58. PubMed ID: 16312137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases.
    Dastidar SG; Rajagopal D; Ray A
    Curr Opin Investig Drugs; 2007 May; 8(5):364-72. PubMed ID: 17520865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological evaluation and molecular modelling studies on benzothiadiazine derivatives as PDE4 selective inhibitors.
    Tait A; Luppi A; Hatzelmann A; Fossa P; Mosti L
    Bioorg Med Chem; 2005 Feb; 13(4):1393-402. PubMed ID: 15670947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase 4-selective inhibition: novel therapy for the inflammation of COPD.
    Jeffery P
    Pulm Pharmacol Ther; 2005; 18(1):9-17. PubMed ID: 15607122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modern therapy of COPD].
    Pariente R; Aubier M
    Bull Acad Natl Med; 2004; 188(1):67-74; discussion 74-5. PubMed ID: 15368926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression.
    Sanz MJ; Cortijo J; Morcillo EJ
    Pharmacol Ther; 2005 Jun; 106(3):269-97. PubMed ID: 15922015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective PDE4 inhibitors as potent anti-inflammatory drugs for the treatment of airway diseases.
    Lagente V; Martin-Chouly C; Boichot E; Martins MA; Silva PM
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():131-6. PubMed ID: 15962112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD).
    Barnette MS
    Prog Drug Res; 1999; 53():193-229. PubMed ID: 10616299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of PDE4 inhibitors in asthma or COPD.
    Spina D
    Curr Opin Investig Drugs; 2000 Oct; 1(2):204-13. PubMed ID: 11249575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selective phosphodiesterase 4 inhibition. Controlling inflammation--also in patients with COPD].
    MMW Fortschr Med; 2004 Apr; 146(18):59. PubMed ID: 15366479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.